Given the dual nature of Bok’s role in cancer (pro-tumorigenic vs. tumor suppressive depending on context) and its unique regulation, a significant knowledge gap lies in precisely identifying the conditions and molecular determinants that dictate its function, and how this can be exploited for targeted therapy. The gene discussed is BOK; the disease is neoplasm.